Caplin Point Laboratories Limited

NSE: CAPLIPOINT · Healthcare

₹2,471.80
-24.30 (-0.97%)

Last close · 30 Aug 2026, 11:53 am IST

Open
₹2,506.90
Day high
₹2,516.80
Day low
₹2,459.80
Volume
50.5 K
Prev close
₹2,496.10

Price chart

Range
EMA
Also show

Fundamentals

Drug Manufacturers - Specialty & Generic

Valuation

Market Cap
18,856 Cr
Price
2,480.70
P/E (TTM)
31.35
P/E (Fwd)
23.20
P/B
5.37
EV/EBITDA
23.54
EV/Revenue
8.19
PEG
Div Yield
0.32%
52W High
2,699.00
52W Low
1,500.30
Beta
0.37

Profitability & income

Revenue (TTM)
2,187 Cr
Net Income (TTM)
641 Cr
EBITDA
761 Cr
Gross Margin
60.42%
Op. Margin
30.90%
Net Margin
29.32%
ROE
19.94%
ROA
11.86%
EPS (TTM)
79.12
EPS (Fwd)
106.95

Financial health

Total Debt
5 Cr
Total Cash
1,007 Cr
Debt/Equity
0.13
Current Ratio
6.70
Quick Ratio
4.94
Book Value
462.02
Free Cash Flow
2 Cr
Op. Cash Flow
523 Cr

Growth

Revenue Growth
19.00%
Earnings Growth
19.40%
Earnings QoQ
19.30%

Quarterly results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-03-31600 Cr170 Cr233 Cr185 Cr355 Cr5 Cr3,586 Cr
2025-12-31543 Cr164 Cr223 Cr170 Cr328 Cr
2025-06-30510 Cr153 Cr201 Cr161 Cr315 Cr
2025-03-31502 Cr143 Cr194 Cr151 Cr301 Cr5 Cr2,850 Cr
2024-12-31493 Cr139 Cr194 Cr146 Cr298 Cr

Annual results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-03-312,187 Cr641 Cr876 Cr688 Cr1,322 Cr523 Cr5 Cr3,586 Cr
2025-03-311,937 Cr536 Cr743 Cr581 Cr1,167 Cr432 Cr5 Cr2,850 Cr
2024-03-311,680 Cr457 Cr619 Cr498 Cr950 Cr318 Cr2 Cr2,316 Cr
2023-03-311,454 Cr376 Cr497 Cr398 Cr785 Cr271 Cr5 Cr1,880 Cr
2022-03-31

Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.

Want charts and signals for CAPLIPOINT?

Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.

Sign in